TDACW
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Financial - Conglomerates · US
$1.25
+9.65%Price chart
Sep 17Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.15
From 52W high−41.86%
Volume513.00
Market cap$21.56M
P/E (TTM)4.9x
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$1.15
From 52W high
−41.86%
Volume
513.00
Market cap
$21.56M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−17.1x
P/E (TTM)
4.9x
RSI (14)
41.9
MomentumView details →
1D Return
+9.65%
YTD Return
+303.23%
Similar companies
BRC Group Holdings, Inc. - Depositary Shares, each representing a 1/1000th fractional interest in a share of Series A Cumulative Perpetual Preferred StockRILYPBayview Acquisition Corp UnitBAYAUJones Ventures INTL Acquisition1 Corp RightsJONERCartesian Growth Corporation IIIFACWWAustralian Oilseeds Holdings Limited WarrantCOOTWColumbus Circle Capital Corp IICMIIWFind similar companies →
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.85d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.106d ago